Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Dec 16 2023
Business
Dec 16 2023
5 min read

Press Release Dec 16 2023

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 16, 2023, titled "Zydus receives approval from USFDA to initiate Phase II clinical trial of ZYIL1 in patients with Parkinson s disease".

View Attachment